Key result
Redo SAVR targets high-risk patients, warranting cautious selection in hemodialysis or high STS-PROM cases.
Why the study?
Long-term outcomes following redo SAVR in Asian patients remain poorly defined, and contemporary benchmarks are needed as transcatheter aortic valve-in-surgical aortic valve procedures expand.
Observational (n=122)
Yes
Answers are grounded in this paper and cite their sources.
Redo SAVR in Japan is primarily performed in older, small-bodied, and relatively high-risk patients, highlighting the need for careful patient selection particularly in those with high STS-PROM or on hemodialysis.
OBJECTIVE: Long-term outcomes following redo surgical aortic valve replacement (SAVR) in Asian patients, who typically have smaller body size than Western populations, remain poorly defined. Contemporary benchmarks are needed as transcatheter aortic valve-in-surgical aortic valve procedures expand. METHODS: We analyzed 122 patients who underwent redo SAVR for prosthetic valve failure at 8 centers between 2015 and 2023. The primary endpoint was all-cause mortality. Secondary endpoints were cardiac mortality and major adverse cardiovascular and cerebrovascular events (MACCE). CONCLUSIONS: Redo SAVR was performed primarily in older, small-bodied, and relatively high-risk Asian patients. Careful patient selection may be warranted, particularly in patients with high STS-PROM or those undergoing hemodialysis.
No takes yet. Share an insight, caveat, or question.
Handa et al. (2026) conducted an observational in Prosthetic aortic valve failure (n=122). Redo surgical aortic valve replacement (SAVR) was evaluated on All-cause mortality. Redo SAVR in 122 Japanese patients targeted high-risk individuals, warranting careful selection in those with high STS-PROM or on hemodialysis.
Synapse has enriched 10 related papers. Consider them for comparative context: